Molecular Formula | C20H15ClF3N5 |
Molar Mass | 417.8148 |
Density | 1.458±0.06 g/cm3(Predicted) |
Solubility | DMSO: ≥ 30 mg/mL |
Appearance | Form solid, color White |
pKa | 12.81±0.40(Predicted) |
Storage Condition | -20°C |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months. |
Physical and Chemical Properties | Bioactive Pexidartinib (PLX3397) is an orally effective multi-target CSF-1R,Kit (c-Kit), and FLT3 receptor tyrosine kinase inhibitor with IC50 of 20 nM, 10 nM, and 160 nM, respectively. Pexidartinib (PLX3397) can induce apoptosis and necrosis and has antitumor activity. Phase 3. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.393 ml | 11.967 ml | 23.934 ml |
5 mM | 0.479 ml | 2.393 ml | 4.787 ml |
10 mM | 0.239 ml | 1.197 ml | 2.393 ml |
5 mM | 0.048 ml | 0.239 ml | 0.479 ml |